Benign neoplasm: Lip

CD2_BENIGN_LIP

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 D10.0
  • Hospital discharge: ICD-9 2100
  • Hospital discharge: ICD-8 2100
  • Cause of death: ICD-10 D10.0
  • Cause of death: ICD-9 2100
  • Cause of death: ICD-8 2100

2 out of 7 registries used, show all original rules.

776

4. Check minimum number of events

None

776

5. Include endpoints

None

776

6. Filter based on genotype QC (FinnGen only)

776

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D10
Name in latin
Neoplasma benignum labii (oris)

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 5939 2865 3040
Only index persons 5167 2575 2592
Unadjusted period prevalence (%)
Whole population 0.08 0.08 0.08
Only index persons 0.10 0.09 0.10
Median age at first event (years)
Whole population 56.86 56.25 57.39
Only index persons 55.08 55.45 54.71

-FinnGen-

Key figures

All Female Male
Number of individuals 776 391 385
Unadjusted period prevalence (%) 0.15 0.13 0.17
Median age at first event (years) 59.23 55.57 62.95

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
710
Matched controls
7099
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D10.09
ICD-10 Finland
Benign tumor of the lip UNS
3362.3
269.5
243
*
EAA10
NOMESCO Finland
Excision of lesion of lip
215.1
213.4
212
14
D10.04
ICD-10 Finland
Lower lip tumor in the lower lip mucosa
+∞
196.2
179
*
D10.00
ICD-10 Finland
Upper lip tumor in upper lip on lip lip border
+∞
114.8
107
*
D10.01
ICD-10 Finland
Uper lip tumor in the upper lip mucosa
+∞
64.6
61
*
TEA00
NOMESCO Finland
Biopsy of lip
34.5
61.5
80
26
D10.03
ICD-10 Finland
Lower lip tumor in the lower lip at the lip red border
+∞
52.8
50
*
D10.0
ICD-10 Finland
Benign neoplasm: Lip
386.6
37.4
37
*
21000
ICD-8 Finland
Benign neoplasm of buccal cavity and pharynx, Lip
+∞
34.7
33
*
8070/3-C00.1
ICD-O-3
Squamous cell carcinoma, NOS, of external lower lip
107.9
28.9
31
*
2100A
ICD-9 Finland
Benign neoplasm of lip, oral cavity and pharynx, Lip
+∞
28.3
27
*
C00.1
ICD-10 Finland
Malignant neoplasm: External lower lip
237.3
22.7
23
*
C44.02
ICD-10 Finland
Spinocellular carcinoma of the lip skin
82.8
21.8
24
*
EAA30
NOMESCO Finland
Partial excision of lower lip
108.0
19.7
21
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.3
18.0
97
326
D10.05
ICD-10 Finland
Lower lip tumor in lower lip mucosa and on lip lip border
+∞
15.7
15
*
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
6.5
15.4
40
65
4381
FHL
Exemption of local change
46.0
15.1
18
*
D20
ICPC
Mouth/tongue/lip symptom/complaint
3.8
10.5
44
122
K11.69
ICD-10 Finland
Mukocele UNS
33.0
10.4
13
*
D18.0
ICD-10 Finland
Haemangioma, any site
5.0
9.7
30
62
C00.9
ICD-10 Finland
Malignant neoplasm: Lip, unspecified
101.3
9.4
10
*
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
4.5
9.0
31
72
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.0
9.0
51
177
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.8
8.2
157
965
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
3.8
8.1
33
90
D23.0
ICD-10 Finland
Benign neoplasm: Skin of lip
17.4
8.1
12
7
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.9
8.1
127
733
D83
ICPC
Mouth/tongue/lip disease
13.2
7.9
13
10
R01AD09
ATC
mometasone; nasal
1.6
7.5
278
2058
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
3.3
6.9
32
99
K13.03
ICD-10 Finland
Keilit UNS
16.9
6.8
10
6
SXA10
NOMESCO Finland
Epithel biopsy of mouth
6.0
6.6
17
29
J01DB01
ATC
cefalexin; oral
1.6
6.5
541
4755
SPAT1153
SPAT
Removal of sutures
1.6
6.4
219
1576
N05CF01
ATC
zopiclone; oral
1.6
6.3
217
1562
EKB00
NOMESCO Finland
Excision of lesion of cheek
11.1
6.3
11
10
L57.0
ICD-10 Finland
Actinic keratosis
2.0
6.3
76
395
SAA01
NOMESCO Finland
Simple examination of mouth
1.5
6.0
439
3707

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768804) Tissue Pathology biopsy report
384
2483
2.08
21.92
2.5
2.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
141
815
1.89
9.80
4.5
4.6
%
35.5
32.3
2.22
79
544
(3019225) pH of Specimen
117
648
1.95
9.22
4.0
4.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
128
781
1.77
7.36
8.2
7.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
515
4364
1.54
7.17
4.7
4.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
366
2907
1.49
6.85
5.2
5.8
mmol/l
1.2
1.2
0.26
305
2611
(42870588) Differential panel, method unspecified - Blood
277
2089
1.51
6.62
5.8
5.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
391
3179
1.46
6.32
5.9
6.6
mmol/l
1.2
1.2
0.02
323
2674
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
557
4869
1.51
6.12
7.9
7.6
u/l
79.4
79.3
0.01
518
4562
(3013115) Eosinophils [#/volume] in Blood
391
3206
1.44
5.89
5.8
5.9
e9/l
0.2
0.2
0.02
333
2817
(3013512) EKG study
254
1934
1.47
5.60
4.3
4.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
423
3564
1.41
5.23
2.7
2.9
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
129
864
1.59
5.15
24.8
25.4
inr
1.3
1.3
0.01
18
117
(40768443) Skin Pathology biopsy report
53
276
1.99
5.00
1.2
1.3
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
372
3081
1.40
5.00
5.6
5.6
e9/l
0.6
0.6
0.40
318
2665
(3006504) Eosinophils/100 leukocytes in Blood
354
2911
1.40
4.95
5.7
5.7
%
2.8
2.9
0.18
321
2720
(3019198) Lymphocytes [#/volume] in Blood
380
3163
1.39
4.94
5.7
5.7
e9/l
1.8
1.9
0.18
330
2774
(3022096) Basophils/100 leukocytes in Blood
345
2827
1.40
4.91
5.9
5.7
%
0.6
0.7
1.19
311
2647
(3006315) Basophils [#/volume] in Blood
373
3097
1.39
4.91
5.7
5.6
e9/l
0.0
0.0
2.01
322
2684
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
52
271
1.98
4.90
1.8
1.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
328
2680
1.39
4.69
2.2
2.0
pmol/l
94.7
94.6
0.01
158
1384
(3019069) Monocytes/100 leukocytes in Blood
353
2922
1.38
4.65
6.2
6.0
%
8.6
8.8
0.45
321
2748
(3013707) Erythrocyte sedimentation rate by Westergren method
527
4660
1.41
4.65
4.9
4.2
mm/h
12.9
12.7
0.11
464
4270
(3002030) Lymphocytes/100 leukocytes in Blood
359
2984
1.38
4.59
6.0
5.9
%
27.7
27.2
0.43
321
2786
(3009542) Hematocrit [Volume Fraction] of Blood
609
5540
1.46
4.48
18.2
16.0
%
39.8
39.7
0.09
388
3823
(3018010) Neutrophils/100 leukocytes in Blood
354
2945
1.37
4.47
5.6
5.6
%
57.5
57.7
0.07
321
2766
(3013826) Glucose [Moles/volume] in Serum or Plasma
438
3770
1.37
4.46
4.6
4.7
mmol/l
6.9
6.7
0.55
409
3540
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
18
60
3.05
4.42
1.6
1.5
u/l
13.9
29.1
1.26
11
48
(3013650) Neutrophils [#/volume] in Blood by Automated count
421
3613
1.36
4.30
8.8
9.1
e9/l
3.9
4.1
1.66
365
3181
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
47
249
1.94
4.26
1.6
1.7
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
14
41
3.46
4.20
2.6
1.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
272
2186
1.38
4.19
3.0
3.4
mmol/l
2.4
2.4
0.27
220
1900
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
106
714
1.56
4.12
3.6
3.9
u/l
219.0
253.5
1.62
94
667
(3017732) Neutrophils [#/volume] in Blood
69
419
1.71
4.04
3.0
2.8
e9/l
3.9
4.0
0.19
36
321
(4035726)
84
545
1.61
3.83
1.4
1.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
13
39
3.37
3.77
3.3
2.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
614
5652
1.41
3.73
5.5
4.7
mu/l
1.9
2.1
0.60
535
5115
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
200
1560
1.38
3.63
2.5
2.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
21
87
2.45
3.49
1.7
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
659
6165
1.46
3.47
17.1
15.0
mg/l
22.7
24.7
0.96
543
4963
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
82
543
1.57
3.44
3.0
3.0
ng/l
122.6
212.0
3.70
71
495
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
21
88
2.42
3.42
1.7
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
21
88
2.42
3.42
1.7
1.3
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
18
70
2.61
3.40
1.9
1.5
%
41.1
65.7
1.62
13
51
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
21
89
2.40
3.34
1.7
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
21
89
2.40
3.34
1.7
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
21
89
2.40
3.34
1.7
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
646
6044
1.41
3.19
5.1
4.7
mmol/l
6.0
6.0
0.05
558
5472
(3044640) Blood type and Crossmatch panel - Blood
248
2036
1.32
3.16
2.6
2.4
—
—
—
0
0
(3002256) Pathology report gross observation
111
800
1.45
3.13
1.3
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
52
322
1.66
2.89
3.5
3.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
299
2546
1.28
2.84
2.4
2.2
nmol/l
77.3
77.6
0.06
245
2251
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
626
5861
1.35
2.79
4.3
4.0
mmol/l
1.3
1.3
0.19
537
5321
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
143
1104
1.36
2.72
1.8
1.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
342
2973
1.27
2.71
4.0
4.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
661
6249
1.39
2.71
5.4
5.0
mmol/l
2.7
2.7
0.24
575
5706
(3019309) Folate [Moles/volume] in Red Blood Cells
160
1258
1.34
2.71
1.9
1.8
nmol/l
1086.8
1180.8
0.53
100
946
(3023103) Potassium [Moles/volume] in Serum or Plasma
678
6440
1.42
2.68
19.8
17.6
mmol/l
4.0
4.0
1.53
651
6264
(36660697) Celiac disease serology panel - Serum
66
442
1.54
2.68
1.2
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
62
410
1.56
2.66
2.7
3.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
202
1647
1.31
2.65
2.4
2.2
mg/l
2.9
3.1
0.59
156
1389
(3019550) Sodium [Moles/volume] in Serum or Plasma
676
6422
1.41
2.63
19.7
17.4
mmol/l
139.7
139.7
0.02
652
6252
(4010399)
67
454
1.52
2.58
1.4
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
648
6120
1.36
2.56
4.9
4.5
mmol/l
4.6
4.6
0.56
570
5625
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
10
33
3.06
2.53
1.8
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
310
2681
1.26
2.52
8.3
9.6
inr
1.2
1.3
0.26
61
762
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
235
1969
1.28
2.48
2.3
2.1
u/l
179.3
266.6
1.15
213
1853
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
448
4047
1.25
2.47
3.2
3.1
u/l
47.7
50.6
0.35
405
3762
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
99
732
1.40
2.45
2.7
2.8
umol/l
7.7
8.7
0.18
88
655
(40768797) Stomach Pathology biopsy report
116
881
1.37
2.45
1.1
1.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
43
270
1.63
2.31
3.5
4.1
mmol/l
25.0
25.1
0.06
35
255
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
688
6584
1.40
2.29
12.1
10.7
u/l
27.8
26.1
0.68
657
6338
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
642
6080
1.32
2.29
5.0
4.5
mmol/l
1.4
1.5
0.49
561
5553
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
37
224
1.68
2.28
1.0
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
173
2091
0.78
2.23
3.1
3.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
80
580
1.42
2.22
2.7
2.5
ug/l
5.8
6.8
0.27
63
512
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
506
4664
1.24
2.20
4.4
3.9
pmol/l
14.9
14.8
0.07
424
4200
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
161
1307
1.29
2.16
1.2
1.2
u/ml
2.4
1.4
0.34
31
347
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
17
81
2.12
2.14
1.5
2.6
—
24.3
—
0
20
(3024731) MCV [Entitic volume]
710
6845
1.44
2.13
25.3
21.9
fl
91.1
91.2
0.43
695
6728
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
376
3369
1.23
2.11
6.2
6.2
umol/l
11.9
11.3
0.29
350
3202
(3010813) Leukocytes [#/volume] in Blood
710
6847
1.43
2.11
25.4
22.0
e9/l
6.9
6.7
0.31
686
6645
(3026361) Erythrocytes [#/volume] in Blood
710
6847
1.43
2.11
25.4
22.0
e12/l
4.5
4.5
0.04
686
6647
(3000963) Hemoglobin [Mass/volume] in Blood
710
6849
1.43
2.08
25.5
22.1
g/l
134.5
134.9
0.29
695
6728
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
611
5770
1.28
2.08
6.4
6.1
mmol/mol
40.3
40.1
0.22
535
5311
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
31
184
1.71
2.07
1.6
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
27
154
1.78
2.06
1.4
1.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
235
2012
1.24
2.01
2.6
2.4
u/l
60.2
56.5
0.76
210
1857
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
26
148
1.78
2.00
1.8
1.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
316
2793
1.22
1.99
4.7
4.7
g/l
35.5
35.3
0.30
286
2598
(3035941) MCH [Entitic mass]
709
6846
1.41
1.98
25.3
21.9
pg
30.3
30.4
0.29
695
6727
(3021960) Folate [Moles/volume] in Serum or Plasma
193
1622
1.25
1.94
1.7
1.6
nmol/l
21.6
20.6
0.31
149
1361
(3003129) Base excess in Capillary blood by calculation
6
16
3.77
1.94
2.5
1.1
mmol/l
0.6
2.8
—
6
16
(3012544) pH of Venous blood
82
613
1.38
1.93
3.8
3.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
618
5863
1.27
1.90
15.7
14.0
ml/min/173m2
78.4
79.0
0.28
513
4837
(3014599) Egg white IgE Ab [Units/volume] in Serum
8
28
2.88
1.86
1.0
1.0
—
0.2
—
0
6
(3000330) Specific gravity of Urine by Test strip
48
327
1.50
1.86
2.6
3.8
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
11
46
2.41
1.86
3.5
2.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
8
181
0.44
1.83
1.5
1.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
91
701
1.34
1.79
2.6
4.3
ug/l
4.4
25.2
1.16
67
590
(3014051) Protein [Presence] in Urine by Test strip
24
139
1.75
1.77
2.5
2.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
257
1.54
1.77
3.4
2.3
g/l
3.9
3.7
0.25
21
191
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
37
241
1.56
1.76
2.5
2.3
g/l
11.6
10.6
0.35
24
204
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
61
441
1.42
1.76
3.9
3.5
kpa
4.9
5.1
1.40
54
408
(3007461) Platelets [#/volume] in Blood
707
6843
1.37
1.75
25.4
22.0
e9/l
248.4
246.2
0.38
688
6661
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
258
1.54
1.74
3.4
2.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
258
1.54
1.74
3.4
2.3
g/l
7.7
7.4
0.34
22
197
(3002032) Base excess in Venous blood by calculation
79
598
1.36
1.74
3.5
3.6
mmol/l
2.3
1.9
0.44
63
483
(3010144) Erythrocytes [#/volume] in Synovial fluid
13
61
2.15
1.72
1.5
1.3
e6/l
4224.3
309760.7
—
8
40
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
5
13
3.86
1.71
4.2
2.3
ug/l
0.8
1.1
—
5
13
(3033658) Prothrombin time (PT) actual/Normal
188
1597
1.23
1.71
4.0
3.9
%
91.9
89.1
0.77
179
1562
(40761511) CBC panel - Blood by Automated count
668
6419
1.29
1.70
16.4
14.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
39
260
1.53
1.69
2.1
1.9
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
56
402
1.42
1.69
1.8
1.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
225
1951
1.22
1.67
3.4
3.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
41
278
1.50
1.65
1.1
1.0
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
72
543
1.36
1.63
3.6
3.0
g/l
66.5
66.7
0.10
56
489
(3007164) IgA [Mass/volume] in Serum or Plasma
141
1166
1.26
1.63
1.5
1.5
g/l
2.4
2.5
0.21
78
712
(3023368) Bacteria identified in Blood by Culture
213
1842
1.22
1.62
3.8
4.1
—
—
—
0
0
(4133840)
5
14
3.59
1.61
1.0
1.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
258
2278
1.20
1.58
5.5
5.0
ug/l
4.1
2.8
0.37
220
2028
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
20
114
1.77
1.57
2.4
1.8
pmol/l
187.9
222.1
0.65
20
107
(3000492) Spirometry study
76
582
1.34
1.57
1.4
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
281
2505
1.19
1.54
4.2
3.8
ng/l
43.0
53.4
0.25
207
1814
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
46
327
1.43
1.48
2.4
2.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
76
588
1.32
1.48
3.5
2.4
u/l
36.0
32.6
0.34
58
494
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
228
2002
1.20
1.47
3.1
3.1
ng/l
1420.2
1414.9
0.01
189
1717
(3023520) Reticulocytes [#/volume] in Blood
73
562
1.33
1.47
4.5
2.5
e9/l
75.0
69.7
0.65
56
434
(3001122) Ferritin [Mass/volume] in Serum or Plasma
296
2660
1.18
1.47
3.1
2.7
ug/l
144.1
130.2
0.23
258
2429
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
28
2.51
1.45
1.1
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
25
156
1.62
1.45
1.1
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
36
245
1.49
1.45
3.1
2.3
g/l
3.0
3.1
0.24
21
193
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
160
1360
1.22
1.44
1.9
1.7
pmol/l
430.9
4513066.9
0.50
116
1108
(3021387) Prolactin [Units/volume] in Serum or Plasma
24
149
1.63
1.42
1.7
1.6
mu/l
339.7
298.5
0.24
24
136
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
29
2.43
1.39
2.1
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
29
2.43
1.39
2.1
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
55
409
1.37
1.39
3.9
3.6
mmol/l
1.5
1.9
0.33
40
305
(4146454)
13
67
1.96
1.39
1.7
2.8
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
12
60
2.02
1.38
2.7
1.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
103
838
1.26
1.38
4.7
5.4
mmol/l
1.0
1.0
1.06
86
770
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
43
307
1.42
1.37
1.4
1.9
g/l
1.4
1.5
0.43
35
268
(44813793)
9
41
2.21
1.37
1.2
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
53
393
1.37
1.37
1.2
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
65
498
1.33
1.36
3.5
2.7
ml/min/173m2
71.1
66.1
0.48
32
211
(3004588) Protein electrophoresis panel - Serum or Plasma
61
463
1.34
1.36
2.5
2.6
—
—
—
0
0
(4015189)
5
17
2.95
1.36
5.2
2.6
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
260
2324
1.18
1.36
3.5
3.3
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
115
951
1.25
1.35
2.4
2.3
g/l
2.3
2.3
0.05
102
878
(3000991) Gas panel - Venous blood
67
517
1.32
1.34
6.3
8.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
72
562
1.31
1.33
2.9
1.9
nmol/l
360.6
375.0
0.24
65
517
(3004451) EKG impression Narrative
0
40
0.00
1.33
0.0
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
216
1904
1.19
1.33
3.3
3.9
ph
7.4
7.4
0.08
28
361
(3021788) Differential panel - Synovial fluid
20
121
1.67
1.32
1.8
1.5
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
0
41
0.00
1.31
0.0
1.7
—
9.1
—
0
36
(3009508) Creatinine [Moles/volume] in Urine
224
1989
1.18
1.26
3.0
3.1
mmol/l
7.3
7.6
0.30
171
1637
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
130
1100
1.22
1.24
2.9
2.8
e6/l
1.4
1.2
0.23
67
645
(3021589) Normoblasts [#/volume] in Blood
249
2760
0.86
1.24
9.3
9.4
e9/l
0.0
0.0
0.33
202
2258
(3000494) Fungus identified in Specimen by Culture
95
777
1.25
1.23
1.7
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
180
1573
1.19
1.22
5.5
6.6
—
—
—
0
0
(3048879) Bone marrow aspiration report
5
19
2.64
1.21
5.4
2.3
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
19
2.64
1.21
1.8
1.6
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
37
2.17
1.21
2.0
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
37
2.17
1.21
2.0
1.3
—
—
—
0
0
(4306422)
13
71
1.85
1.20
1.2
1.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
25
165
1.53
1.19
1.8
1.6
e6/l
7178.4
16949.8
1.14
18
119
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
57
439
1.32
1.18
2.1
1.9
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
31
215
1.46
1.17
1.8
2.4
g/l
36.9
37.9
0.30
17
181
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
10
50
2.01
1.17
1.8
1.3
%
39.6
28.5
—
5
34
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
20
126
1.60
1.15
2.0
1.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
107
896
1.23
1.13
2.5
2.4
%
22.6
22.6
0.01
86
770
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
145
1251
1.20
1.13
2.7
3.1
mmol/l
2.5
2.4
0.36
128
1100
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
14
80
1.76
1.13
1.0
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
111
935
1.22
1.11
2.2
2.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
31
2.27
1.10
7.1
6.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
91
752
1.24
1.10
2.1
1.7
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
85
699
1.24
1.07
2.6
2.2
ug/g
97.5
129.2
0.95
59
543
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
22
2.28
1.03
2.6
2.8
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
331
3069
1.14
1.00
3.2
3.8
estimate
0.0
0.0
0.00
40
572
(40761535) Cells panel - Urine sediment
67
541
1.26
1.00
2.7
3.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
86
715
1.23
0.99
1.4
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
13
76
1.72
0.99
1.0
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
142
1240
1.18
0.98
5.4
3.9
ng/l
61.6
298.5
4.28
112
991
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
121
1043
1.19
0.97
3.0
3.0
e6/l
3.4
2.2
0.69
59
589
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
7
36
1.95
0.97
5.4
2.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
153
1346
1.17
0.97
1.7
1.7
mg/l
1.1
1.2
0.22
113
1040
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
119
0.50
0.94
1.3
1.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
6
27
2.23
0.93
11.2
17.7
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
12
70
1.73
0.93
1.0
1.1
%
138.4
116.9
—
7
64
(3037522) Nuclear Ab [Titer] in Serum
97
824
1.20
0.92
1.4
1.3
titre
946.7
485.0
0.72
21
183
(3020874) Milk IgE Ab [Units/volume] in Serum
6
28
2.15
0.91
1.0
1.1
—
0.2
—
0
10
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
14
86
1.64
0.91
1.0
1.2
nmol/l
0.6
0.6
0.15
14
78
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
44
341
1.31
0.91
6.4
9.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
26
185
1.42
0.90
1.6
1.5
ug/g
254.9
282.3
0.30
15
112
(3009261) Glucose [Presence] in Urine by Test strip
334
3118
1.13
0.88
3.3
3.8
estimate
0.0
0.0
0.50
40
554
(3025941) Bacteria identified in Stool by Culture
41
317
1.31
0.87
1.4
1.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
30
2.01
0.87
1.2
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
161
1435
1.15
0.86
3.3
3.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
210
1908
1.14
0.86
3.2
3.2
mg/l
289.7
231.7
0.10
135
1216
(3021601) Nitrite [Presence] in Urine by Test strip
330
3083
1.12
0.86
4.6
5.2
estimate
0.0
0.0
0.00
43
572
(3004809) Band form neutrophils/100 leukocytes in Blood
15
96
1.57
0.85
2.6
3.1
%
2.5
1.4
—
8
80
(3024263) Appearance of Synovial fluid
6
31
1.94
0.84
1.5
1.5
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
56
454
1.25
0.83
3.1
2.1
nmol/l
11.3
13.0
0.67
46
400
(3017143) Hepatitis C virus Ab [Presence] in Serum
74
619
1.22
0.83
1.5
1.5
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
42
329
1.29
0.82
2.5
3.3
mmol/l
25.7
25.1
0.53
42
321
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
14
89
1.58
0.81
1.9
1.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
30
224
1.35
0.81
2.4
2.9
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
184
1665
1.14
0.80
2.8
2.8
umol/l
6553.4
7178.8
0.06
148
1429
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
20
139
1.45
0.80
1.2
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
60
494
1.23
0.79
2.1
2.0
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
25
0.00
0.79
0.0
1.1
—
37.4
—
0
5
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
3.1
—
781.6
—
0
25
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
25
0.00
0.79
0.0
2.3
—
4713.4
—
0
14
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
48
1.67
0.79
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
48
1.67
0.79
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
48
1.67
0.79
1.1
1.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
118
1037
1.16
0.77
2.5
2.4
umol/l
13.0
12.8
0.09
103
955
(3023487) Leukocytes [#/volume] in Peritoneal fluid
0
28
0.00
0.76
0.0
2.4
—
365.3
—
0
22
(4024509)
9
53
1.71
0.75
1.3
1.4
—
—
—
0
0
(4268621)
9
54
1.67
0.74
2.2
2.4
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
5
24
2.09
0.74
2.6
3.4
umol/l
28.6
33.4
—
5
19
(3030467) Casts [#/volume] in Urine by Automated count
196
1791
1.13
0.73
3.5
3.2
e6/l
0.3
0.5
0.51
142
1368
(36304419) Bacteria [Presence] in Urine
189
1725
1.13
0.72
3.5
3.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
57
683
0.82
0.72
3.0
3.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
48
391
1.24
0.71
1.3
1.4
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
35
274
1.29
0.71
3.1
3.4
u/ml
459.7
1181.2
0.53
28
234
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
22
160
1.39
0.71
1.5
1.2
u/ml
2.6
6.8
—
5
26
(3018095) Leukocytes [#/volume] in Urine
245
2273
1.11
0.70
4.0
3.9
e6/l
55.2
137.5
1.36
166
1639
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
89
772
1.17
0.70
1.8
1.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
150
1658
0.88
0.70
3.7
4.1
estimate
0.0
0.0
0.69
39
556
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
29
222
1.32
0.69
3.0
2.5
g/l
2.8
0.9
0.64
19
194
(40768793) Breast Pathology biopsy report
20
144
1.40
0.68
1.6
1.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
88
765
1.17
0.67
3.1
2.5
%
2.1
1.8
1.60
70
687
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
92
0.54
0.67
1.2
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
20
145
1.39
0.66
1.1
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
28
1.79
0.66
2.6
1.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
28
1.79
0.66
2.6
1.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
218
2018
1.11
0.65
3.8
3.9
mg/mmol
18.9
9.3
0.48
130
1265
(3011648) Oxygen content in Venous blood
7
44
1.60
0.65
2.9
1.7
%
13.0
10.3
—
7
44
(3012501) Base excess in Blood by calculation
19
137
1.40
0.65
5.1
4.1
mmol/l
1.5
2.8
—
10
94
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
29
1.73
0.64
1.0
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
29
1.73
0.64
2.6
1.7
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
5
29
1.73
0.64
3.0
2.4
umol/l
40.0
47.0
—
5
22
(3019230) Fractional oxyhemoglobin in Venous blood
16
112
1.44
0.64
3.4
2.0
%
69.5
59.9
1.33
16
112
(46235355) HIV 1 and 2 tests - Meaningful Use set
99
874
1.15
0.63
1.7
1.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
44
532
0.82
0.62
3.7
3.9
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
150
1363
1.12
0.62
2.8
2.6
e6/l
3.9
5.4
1.17
131
1204
(3026389) Candida sp identified in Specimen by Organism specific culture
11
71
1.56
0.62
1.4
1.4
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
33
262
1.27
0.62
1.8
2.1
u/l
40.8
38.4
0.33
26
231
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
30
1.67
0.61
1.2
1.3
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
0
20
0.00
0.60
0.0
1.2
—
17.1
—
0
13
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
25
192
1.31
0.60
1.5
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
0
22
0.00
0.59
0.0
1.0
—
4.5
—
0
17
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
23
0.00
0.58
0.0
2.1
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
13
89
1.47
0.58
1.1
1.1
—
8.2
—
0
5
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54
457
1.20
0.58
1.9
1.5
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
6
35
1.72
0.57
1.2
1.3
ug/l
2.3
3.6
—
6
26
(3045424) Erythrocytes [Presence] in Urine
14
98
1.44
0.57
1.3
1.3
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
116
1045
1.13
0.56
3.8
3.2
mmol/l
0.8
0.8
0.33
103
973
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
87
0.57
0.56
1.4
1.5
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
35
284
1.24
0.56
3.5
3.5
u/ml
14.5
67.2
2.32
35
270
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
55
1.46
0.56
1.5
1.0
—
—
—
0
0
(3000012) Reticulocyte production index
6
37
1.63
0.55
2.0
1.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
15
205
0.73
0.55
2.9
2.5
u/ml
0.3
0.4
—
10
111
(3036489) Thrombin time
26
205
1.28
0.53
1.8
2.0
s
21.1
21.3
0.08
20
184
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
63
1.43
0.52
4.4
2.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
57
491
1.17
0.52
3.3
4.0
ng/l
76.9
86.7
0.62
45
438
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
25
197
1.28
0.51
1.8
2.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
11
75
1.47
0.51
1.8
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
13
92
1.42
0.50
1.8
2.8
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
21
162
1.30
0.50
2.0
1.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
39
464
0.83
0.50
3.5
4.3
%
0.0
0.8
—
10
122
(3002582) Erythrocytes [#/volume] in Urine
209
1962
1.09
0.47
3.6
3.3
e6/l
63.2
109.7
0.56
158
1530
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
215
2023
1.09
0.46
3.5
3.2
u/l
29.9
32.7
1.13
203
1924
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
7
49
1.43
0.46
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
7
49
1.43
0.46
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
7
49
1.43
0.46
1.1
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
85
763
1.13
0.45
5.4
6.9
mmol/l
1.4
1.4
0.01
65
599
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
104
946
1.11
0.45
1.4
1.5
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
11
152
0.72
0.44
3.0
3.9
mg/l
31.2
27.7
—
6
95
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
17
219
0.77
0.44
1.5
1.9
mg/l
3.1
3.6
—
8
168
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
31
1.62
0.43
1.2
1.2
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
31
1.62
0.43
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
31
1.62
0.43
1.0
1.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
8
56
1.43
0.42
2.5
2.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
8
56
1.43
0.42
1.4
1.9
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
12
87
1.39
0.42
1.1
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
10
70
1.43
0.42
1.9
1.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
8
58
1.38
0.41
1.9
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
33
1.52
0.41
1.6
1.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
11
79
1.40
0.41
1.5
1.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
46
528
0.86
0.41
3.6
3.5
mmol/l
1.2
1.2
1.01
40
456
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
17
0.00
0.40
0.0
2.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
60
1.34
0.40
1.0
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
8
61
1.31
0.39
1.3
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
14
106
1.33
0.39
1.3
1.5
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
16
203
0.78
0.38
1.5
1.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
98
1.33
0.37
1.2
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
37
1.35
0.37
2.0
1.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
22
180
1.23
0.36
2.2
4.9
—
—
—
0
0
(4034850)
16
201
0.79
0.36
10.9
9.6
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
84
767
1.11
0.36
5.5
6.8
kpa
5.1
5.1
0.04
77
730
(3027801) Oxygen [Partial pressure] in Arterial blood
84
768
1.11
0.35
5.5
6.8
kpa
12.4
12.1
0.30
77
734
(3019150) Specific gravity of Urine by Refractometry
146
1370
1.08
0.35
3.5
4.1
kg/l
1.0
1.0
0.21
30
191
(3042111) Morphology [Interpretation] in Bone marrow Narrative
14
109
1.29
0.33
1.6
1.6
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
10
74
1.36
0.32
1.1
1.1
u/ml
0.7
1.3
—
5
25
(3037756) Immunofixation for Serum or Plasma
18
146
1.24
0.32
1.8
1.7
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
17
137
1.25
0.32
1.1
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
26
220
1.19
0.32
1.7
2.0
—
—
—
0
0
(3026782) Osmolality of Urine
137
1288
1.08
0.32
2.8
2.8
mosm/kgh2o
538.4
556.7
0.47
110
1100
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
105
977
1.09
0.31
1.3
1.3
u/ml
6.3
12.1
0.56
35
369
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
69
629
1.11
0.31
1.8
1.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
496
5061
0.94
0.31
20.4
18.3
%
13.7
13.7
0.04
490
4958
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
45
400
1.13
0.31
2.8
2.5
—
19.0
—
0
16
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
96
0.73
0.31
1.4
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
7
53
1.32
0.31
1.1
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
55
1.28
0.30
1.1
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
41
461
0.88
0.29
1.5
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
56
1.25
0.29
1.1
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
17
139
1.23
0.29
3.1
2.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
15
121
1.24
0.28
2.7
2.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
14
112
1.25
0.28
1.1
1.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
18
215
0.83
0.27
1.1
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
14
113
1.24
0.26
1.1
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
141
1338
1.07
0.26
4.9
4.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
71
0.70
0.26
2.2
3.7
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
73
0.68
0.26
2.2
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
125
1320
0.94
0.25
3.3
3.0
ug/l
0.8
0.8
0.10
71
877
(3028707) Methadone [Presence] in Urine by Screen method
9
73
1.24
0.25
1.7
2.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
74
1.22
0.25
2.7
3.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
9
76
1.19
0.24
1.0
1.2
nmol/l
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
23
265
0.86
0.24
1.1
1.1
—
28.5
—
0
6
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
20
171
1.17
0.23
1.3
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
17
143
1.19
0.23
1.2
1.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
38
1.32
0.23
2.6
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
38
1.32
0.23
2.6
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
38
1.32
0.23
2.6
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
38
1.32
0.23
2.6
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
32
285
1.13
0.23
3.2
2.8
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
39
1.28
0.23
1.8
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
436
4442
0.96
0.22
4.2
3.9
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
83
778
1.07
0.22
1.9
1.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
42
381
1.11
0.22
1.6
1.6
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
35
314
1.12
0.22
3.0
3.8
%
52.2
47.9
0.43
35
309
(3004616) Nuclear Ab [Presence] in Serum
10
79
1.27
0.22
1.6
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
22
191
1.16
0.22
3.0
3.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
41
1.22
0.22
1.2
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
85
799
1.07
0.22
1.5
1.4
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
11
0.00
0.21
0.0
7.6
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
10
0.00
0.21
0.0
11.3
—
6.1
—
0
10
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
101
0.79
0.21
1.8
1.7
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
12
0.00
0.21
0.0
7.2
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
22
251
0.87
0.21
1.9
1.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
161
1675
0.95
0.21
1.8
1.6
mmol/l
1.3
1.4
0.42
130
1400
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
13
0.00
0.21
0.0
1.6
—
1.2
—
0
13
(3005011) Chlamydia sp Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.0
—
23.4
—
0
13
(3041096) Erythrocytes [Presence] in Urine by Automated
162
1684
0.95
0.20
3.0
3.5
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
6
48
1.25
0.20
1.2
1.1
—
2.4
—
0
9
(3034988) Calcium [Moles/volume] in Capillary blood
0
14
0.00
0.20
0.0
1.6
—
1.2
—
0
14
(3002331) Protein [Mass/volume] in Peritoneal fluid
0
14
0.00
0.20
0.0
1.5
—
34.7
—
0
8
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.9
—
18.2
—
0
14
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
109
1037
1.06
0.20
1.3
1.3
iu/ml
18.1
37.5
3.91
34
324
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
49
1.23
0.20
1.2
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
9
115
0.78
0.20
4.6
3.7
%
54.0
57.7
—
9
115
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
78
734
1.07
0.20
1.6
1.6
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
6
51
1.18
0.19
1.2
1.4
—
29.3
—
0
6
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
25
222
1.13
0.19
1.6
1.6
—
131.1
—
0
9
(3032773) Endomysium IgG Ab [Titer] in Serum
6
52
1.16
0.19
1.0
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
10
81
1.24
0.19
1.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
20
175
1.15
0.18
1.6
1.9
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
25
279
0.89
0.18
1.8
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
28
310
0.90
0.18
1.7
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
12
142
0.84
0.17
1.9
1.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
62
1.13
0.17
1.6
3.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
66
0.76
0.17
1.4
1.6
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
67
0.74
0.17
1.0
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
6
77
0.78
0.15
1.3
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
18
159
1.14
0.15
1.7
1.6
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
9
80
1.13
0.15
1.3
1.3
mu/l
11.1
49.6
—
9
72
(44790047)
9
81
1.11
0.15
1.4
1.5
—
—
—
0
0
(44806118)
9
81
1.11
0.15
1.4
1.5
—
—
—
0
0
(44790049)
9
81
1.11
0.15
1.4
1.5
—
—
—
0
0
(44790048)
9
81
1.11
0.15
1.4
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
82
1.10
0.15
1.1
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
9
82
1.10
0.15
1.0
1.1
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
10
84
1.19
0.14
1.0
1.4
g/l
33.3
32.1
—
10
75
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
99
0.81
0.13
2.6
2.6
—
—
—
0
0
(3010421) pH of Blood
19
170
1.12
0.13
5.1
3.9
ph
7.4
7.4
0.37
19
136
(21494755) Public health laboratory ask at order entry panel
45
479
0.94
0.13
1.4
1.4
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
17
151
1.13
0.13
3.8
3.4
nmol/l
0.8
0.9
0.33
12
121
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
17
151
1.13
0.13
1.5
1.3
miu/ml
205.9
241.4
—
7
75
(3048929) Epstein Barr virus Ab [Presence] in Serum
14
159
0.88
0.13
1.2
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
108
0.83
0.13
1.1
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
109
0.82
0.13
1.1
1.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
9
110
0.82
0.13
4.2
3.3
e9/l
2.6
4.3
—
9
110
(3000764) Benzodiazepines [Presence] in Urine
14
158
0.88
0.12
1.5
1.8
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
10
116
0.86
0.12
2.1
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
234
2385
0.97
0.11
3.5
4.0
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
36
337
1.07
0.11
4.8
3.3
pmol/l
4.5
4.6
0.17
28
291
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
30
280
1.07
0.10
2.0
1.8
ug/l
0.9
2.6
0.97
22
248
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
11
96
1.15
0.10
1.3
1.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
186
1824
1.03
0.09
4.8
4.3
%
22.1
21.5
0.21
75
876
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
24
223
1.08
0.09
1.5
1.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
6
54
1.11
0.09
1.3
1.2
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
6
56
1.07
0.08
2.7
1.9
—
1.7
—
0
5
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
57
1.05
0.08
1.0
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
6
57
1.05
0.08
1.0
1.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
65
0.77
0.08
1.0
1.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
65
0.77
0.08
2.4
1.4
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
65
0.77
0.08
1.0
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
7
66
1.06
0.08
1.7
2.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
15
164
0.91
0.08
1.3
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
43
449
0.96
0.07
1.8
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
11
98
1.12
0.07
1.3
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
6
71
0.84
0.07
1.8
2.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
74
1.08
0.07
1.0
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
71
689
1.03
0.07
1.5
1.7
%
1.4
1.5
1.15
54
606
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
83
0.84
0.07
1.0
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
9
84
1.07
0.07
3.0
2.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
44
458
0.96
0.07
4.1
4.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
12
132
0.91
0.06
1.7
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
12
132
0.91
0.06
1.7
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
9
105
0.86
0.06
1.6
2.9
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
48
497
0.96
0.06
3.4
4.3
%
0.1
0.1
0.03
15
144
(3024891) Influenza virus A+B Ag [Presence] in Specimen
17
158
1.08
0.06
1.1
1.2
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
15
162
0.92
0.06
2.3
2.4
g/l
3.3
3.6
0.45
15
156
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
38
394
0.96
0.05
1.2
1.2
iu/ml
180.5
126.6
—
8
157
(3017181) Myelocytes/100 leukocytes in Blood
51
525
0.97
0.05
3.4
4.2
%
1.1
1.0
0.15
16
160
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
20
189
1.06
0.04
1.9
2.5
g/l
0.0
0.0
0.00
15
173
(42529406) Shigella sp [Presence] in Stool by Culture
17
180
0.94
0.04
1.3
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
16
151
1.06
0.03
3.4
4.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
15
159
0.94
0.03
1.5
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
15
159
0.94
0.03
1.5
1.8
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
10
108
0.92
0.03
1.3
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
13
122
1.07
0.02
1.5
2.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
15
158
0.95
0.02
1.5
1.8
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
20
192
1.04
0.02
1.9
2.5
g/l
0.0
0.0
0.00
15
174
(3037121) Protein [Mass/volume] in Urine
25
242
1.03
0.02
2.2
3.2
g/l
0.6
0.2
—
10
94
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
103
1.07
0.02
1.4
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
107
0.93
0.02
1.1
1.4
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
10
107
0.93
0.02
1.2
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
14
133
1.05
0.01
6.9
3.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
17
177
0.96
0.01
1.3
1.2
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
21
203
1.04
0.01
3.0
2.5
g/l
0.0
0.0
0.50
16
185
(1002224) Polysomnography panel
25
257
0.97
0.01
1.0
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
38
387
0.98
0.01
1.3
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
17
176
0.97
0.00
1.3
1.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
17
176
0.97
0.00
2.2
2.4
ug/min
51.9
91.9
—
9
104
(3020891) Body temperature
25
256
0.98
0.00
4.7
4.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
161
1616
1.00
0.00
1.3
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
115
0.96
0.00
1.5
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
17
165
1.03
0.00
1.7
1.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
17
174
0.98
0.00
1.4
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
15
147
1.02
0.00
1.5
1.9
—
—
—
0
0
(4094501)
15
152
0.99
0.00
1.0
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
47
471
1.00
0.00
3.1
4.2
%
0.6
0.4
—
9
116
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
330.6
—
0
5
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
52.4
—
0
5
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
5
0.00
0.00
0.0
5.6
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
9
94
0.96
0.00
1.1
1.4
—
98.9
—
0
17
(3017509) Phencyclidine [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
51
0.98
0.00
7.6
2.5
%
14.2
13.1
—
5
51
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4062490)
5
59
0.85
0.00
1.2
1.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
7
73
0.96
0.00
1.6
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
8
87
0.92
0.00
2.0
1.4
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
58
0.86
0.00
1.2
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
8
81
0.99
0.00
1.6
1.6
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025315) Body weight
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
5
57
0.88
0.00
1.2
1.1
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
52
0.96
0.00
1.0
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
5.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
7
73
0.96
0.00
1.6
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
63
0.95
0.00
1.3
1.2
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
79
1.01
0.00
1.3
1.2
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
91
0.99
0.00
1.4
1.6
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
69
1.01
0.00
2.4
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
69
1.01
0.00
2.4
1.5
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
7
73
0.96
0.00
1.6
1.5
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
7
0.00
0.00
0.0
1.0
—
18.1
—
0
7
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
7
73
0.96
0.00
1.6
1.5
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
6
66
0.91
0.00
1.0
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
69
1.01
0.00
2.4
1.5
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint CD2_BENIGN_LIP and mortality.

Females

Parameter HR [95% CI] p-value
CD2_BENIGN_LIP 1.028 [0.9, 1.17] 0.68
Birth year 0.996 [0.99, 1.0] 0.394

During the follow-up period (1.1.1998 — 31.12.2019), 393 out of 2264 females with CD2_BENIGN_LIP died.

Males

Parameter HR [95% CI] p-value
CD2_BENIGN_LIP 1.101 [0.97, 1.24] 0.126
Birth year 0.988 [0.98, 1.0] 0.021

During the follow-up period (1.1.1998 — 31.12.2019), 600 out of 2302 males with CD2_BENIGN_LIP died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_LIP.

N-year risk Females Males
1 0.092% 0.172%
5 0.595% 1.164%
10 1.653% 3.209%
15 3.195% 6.197%
20 5.499% 10.545%

Relationships between endpoints

Index endpoint: CD2_BENIGN_LIP – Benign neoplasm: Lip

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data